Seshadri Neervannan

Chief Operating Officer

Seshadri Neervannan (Chief Operating Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $772K of TARS (11,324 sh across 3 lots, as filed), executed Mar 17.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.0M

shares × price, as filed

Last traded

Sep 4

Filed Sep 9

Median ADV $68.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $2.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

TARS

Tarsus Pharmaceuticals, Inc. TARS · 0 buys · 5 sells 5 filings

Recent filings

TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $388K
4,564 sh × $85.00
Exec Sep 4
Filed Sep 9 · 4:12 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $200K
2,989 sh × $66.75
Exec Mar 20
Filed Mar 24 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $772K
11,324 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $641K
8,366 sh × $76.67
Exec Mar 4
Filed Mar 5 · 5:30 PM ET TARSSALE Tarsus Pharmaceuticals, Inc. View filing → $363K
7,583 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET